A Phase 2, randomized, double blind, placebo-controlled study of zanubrutinib treatment in patients hospitalized for COVID-19 infection and pulmonary distress

 IMAGE   09/2020

For more information about this resource, please submit a medical information request.

Rating

Rate this resource